Search results
Moderna (MRNA) Submits Updated COVID-19 Jab to FDA for Review
Zacks via Yahoo Finance· 3 hours agoModerna (MRNA) completes regulatory filing of its Spikevax 2024-2025 formula, targeting the COVID-19...
GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years
Zacks via Yahoo Finance· 3 hours agoAbrysvo recorded sales of $890 million in 2023. In April this year, Pfizer announced that a phase...
FDA vaccine advisers vote unanimously in favor of updated Covid-19 shot for fall
CNN.com· 5 days agoThe committee voted on the question, “For the 2024-2025 Formula of COVID-19 vaccines in the U.S.,...
FDA Gives Nod to RSV Vaccine for People in Their 50s
US News & World Report· 3 hours agoAdministration on Friday has for the first time approved the use of a respiratory syncytial virus (RSV) vaccine for people in their 50s who are at increased risk for the illness. Drugmaker GSK's ...
Updated Covid-19 Vaccine Targeting JN.1 Recommended By FDA Panel
Forbes· 5 days agoThe Vaccines and Related Biological Products Advisory Committee of the FDA evaluated the...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 3 days agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Weik Capital Management Sells 10,839 Shares of Pfizer Inc. (NYSE:PFE)
ETF DAILY NEWS· 1 day agoWeik Capital Management decreased its position in Pfizer Inc. (NYSE:PFE – Free Report) by 26.3% in the 4th quarter, according to the company in its most recent filing with ...
FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
NBC 10 - FOX 14 Monroe· 5 days agoWASHINGTON (AP) — Government advisers Wednesday said it’s time to update the recipe for the COVID-19...
FDA Advisers Recommend Omicron-Focused COVID Boosters for Fall
Homenewshere.com· 4 days agoFDA advisers recommended that the new COVID-19 boosters for fall target the Omicron variant, which...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA TODAY via Yahoo News· 6 hours agoModerna has not said when the combination vaccine might be evaluated by the FDA. Both Pfizer-BioNTech and Novavax are studying combination vaccines to protect ...
